CVS Health Corporation (CVS)
CVS Investors Are Invited To Take The Lead In The CVS Health Corporation Securities Fraud Case With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against CVS Health Corporation ("CVS" or "the Company") (NYSE: CVS ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 3, 2023 and April 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before September 10, 2024.
CVS Health Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – CVS
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
‘Frustrating quarter': CVS Health predicts medical costs will be higher in the second half of the year
CVS Health said on Wednesday that high demand for medical care among older adults hit second-quarter results, a trend that continued into July, causing it to slash its 2024 earnings forecast.
Shareholders of CVS Health Corporation Should Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights - CVS
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadlines - CVS
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or the "Company") (NYSE:CVS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-05303, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CVS securities between May 3, 2023 and April 30, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
CVS Health Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights - CVS
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds CVS Health Corporation Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CVS securities between May 3, 2023, and April 30, 2024, inclusive (the "Class Period").
CVS Health Stock Drops After Cutting Profit Forecast Again
CVS Health said pressure in its benefits segment prompted another cut to its full-year forecast. Here's what you need to know.
Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation (CVS)
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
CVS cuts outlook, plans $2B cost-cutting effort
CVS said Wednesday that it's launching a multi-year productivity initiative. It also cut its outlook for the year as its health care benefits segment continues to face pressure.
Compared to Estimates, CVS Health (CVS) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CVS Cuts Its Full-Year Profit Outlook, Again
CVS Health (CVS) shares lost ground in early trading Wednesday after the pharmacy giant slashed its 2024 earnings guidance again amid increased medical costs and announced the departure of the head of its Aetna unit.
